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MAP Kinase Signaling Specificity Mediated
by the LIN-1 Ets/LIN-31 WH Transcription Factor
Complex during C. elegans Vulval Induction
that these tissue-specific effectors may contribute to
the specificity of MAP kinase signaling.
In Caenorhabditis elegans, the MAP kinase signaling
pathway is required for the development of multiple tis-
sues: the hermaphrodite vulva, the male tail, the excre-
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tory system, the germline, the sex myoblasts, and possi-
bly the posterior ectoderm as well (Church et al., 1995;
Sundaram et al., 1996; M. R. L. and S. K. K., unpublished
Summary data). Of these tissues, the function of MAP kinase in
the vulva has been the best characterized. During the
The let-23 receptor/mpk-1 MAP kinase signaling path- L1 larval stage, six vulval precursor cells (P3.p±P8.p) are
way induces the vulva in C. elegans. We show that generated along the ventral midline of the worm. LIN-3,
MPK-1 directly regulates both the LIN-31 winged-helix a protein similar to epidermal growth factor, is produced
and the LIN-1 Ets transcription factors to specify the by the gonadal anchor cell and initiates vulval develop-
vulval cell fate. lin-31 and lin-1 act genetically down- ment by activating the EGF receptor tyrosine kinase
stream of mpk-1, and both proteins can be directly homolog LET-23 in the closest vulval precursor cell
phosphorylated by MAP kinase. LIN-31 binds to LIN-1, (P6.p). Activation of LET-23 RTK triggers a conserved
and theLIN-1/LIN-31 complex inhibits vulval induction. Grb2/Ras/Raf/MEK/MAP kinase cascade, the compo-
Phosphorylation of LIN-31 by MPK-1 disrupts the LIN-1/ nents of which are encoded by the genes sem-5, let-
LIN-31 complex, relieving vulval inhibition. Phosphory- 60, lin-45, mek-2, and mpk-1/sur-1, respectively (re-
lated LIN-31 mayalso act asa transcriptional activator, viewed in Kornfeld, 1997). Activation of this signaling
promoting vulval cell fates. LIN-31 is a vulval-specific pathway causes P6.p to generate eight cells that ulti-
effector of MPK-1, while LIN-1 acts as a general ef- mately form the inner cells of the vulva, termed the 18
fector. The partnership of tissue-specific and general cell fate. In addition, activation of LET-23 in P6.p also
effectors may confer specificity onto commonly used results in the production of a lateral signal that induces
signaling pathways, creating distinct tissue-specific the adjacent vulval precursor cells (P5.p and P7.p) to
outcomes. generate seven cells that ultimately form the outer cells
of the vulva, termed the 28 vulval fate. Besides the lateral
signal, low levels of the anchor cell signal may alsoIntroduction
contribute toward expression of the 28 cell fate. The
remaining vulval precursor cells (P3.p, P4.p, and P8.p)The receptor tyrosine kinase (RTK)/Ras/MAP kinase sig-
do not receive either the anchor cell signal or the lateralnaling cascade is an evolutionarily conserved signaling
signal and consequently express the nonvulval, 38 cellpathway that controls key developmental processes,
fate.such as neuronal differentiation, fibroblast proliferation,
In this report, we have focused on two genes (lin-31and cell-type specification (reviewed in Schlessinger
and lin-1) that act downstream of mpk-1. lin-31 encodesand Ullrich, 1992). MAP kinases act at the end of this
a winged helix (WH) transcription factor similar to mam-signaling pathway; upon activation, MAP kinases trans-
malian HNF-3 and Drosophila melanogaster forkheadlocate into the nucleus and phosphorylate transcription
(Miller et al., 1993). lin-31 null mutants exhibit both afactors (reviewed in Treisman, 1996). These transcrip-
partially penetrant vulvaless (Vul) and multivulva (Muv)tion factor targets form crucial links between the pro-
phenotype. Specifically, in about 40% of lin-31 mutantcesses of intercellular signaling and gene expression,
animals, either P5.p, P6.p, or P7.p adopts the 38 nonvul-and they may directly mediate how a cell responds to
val fate instead of the normal 18 or 28 vulval fate, resultingactivation of the MAP kinase signaling pathway. Thus,
in a vulvaless (Vul) phenotype. Conversely, in about 61%it is important to identify functional targets of MAP ki-
of lin-31 mutant animals, either P3.p, P4.p, or P8.p adoptsnase and to determine how phosphorylation of these
the 18 or 28 vulval fate instead of the normal 38 nonvulvalsubstrates regulates cell fate specification.
fate, resulting in a multivulva (Muv) phenotype. This mu-Another key point tounderstand is themolecular basis
tant phenotype suggests that LIN-31 may possess twounderlying signaling specificity (reviewed in Marshall,
activities: one that inhibits vulval induction (in P3.p, P4.p,1995). The MAP kinase signaling pathway acts in many
and P8.p) and another that promotes vulval inductioncell types during development and yet is able to induce
(in P5.p, P6.p, and P7.p).specific and distinct cellular responses in each of these
lin-1 encodes an Ets-related transcription factor andcell types. How can a generally used signaling pathway
acts as an inhibitor of vulval cell fates (Beitel et al., 1995).elicit different responses in distinct tissue types? One
In lin-1 mutants, most vulval precursor cells express 18attractive hypothesis is that there may exist tissue-spe-
or 28 vulval fates, resulting in a Muv phenotype (Kornfeld,cific targets of the MAP kinase signaling cascade and
1997). In wild-type animals, activation of the LET-23
RTK/MPK-1 signaling pathway in P6.p may inactivate
LIN-1 function, allowing this cell to express a vulval fate.*To whom correspondence should be addressed.
In addition to its role in vulval development, lin-1 is also²Present address: University of California, Department of Molecular
and Cell Biology, Berkeley, California 94720. involved in the development of the excretory system,
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Figure 1. lin-31 Acts Genetically Downstream of mpk-1 MAP Kinase
Vulval induction at the L4 stage in (A) wild-type, (B) mpk-1(ga117), (C) lin-31(n1053), and (D) lin-31(1053); mpk-1(ga117) animals. mpk-1(ga117)
animals are 100% Vul (M. R. L., unpublished data), lin-31(n1053) animals are 40% Vul and 61% Muv, and lin-31(n1053); mpk-1(ga117) animals
are 35% Muv. Hypodermal cells derived from the 38 fate are shown as white lines, and vulval cells derived from 18 and 28 cell fates are shown
as arrows. Scale bar is 20 mm for (A), (C), (D), and 10 mm for (B).
the male tail, and the posterior ectoderm (Ferguson and vulvaless (Vul) phenotype, since in these animals, P5.p,
P6.p, and P7.p express 38 nonvulval cell fates instead ofHorvitz, 1985; Han et al., 1990; H. Chamberlin, personal
communication; P. B. T., unpublished observations), 18 or 28 vulval cell fates (M. R. L. and S. K. K., unpublished
data). Conversely, lin-31(null) mutants display a partiallysuggesting that lin-1 may act as a general downstream
effector of MAP kinase signaling in C. elegans. penetrant multivulva (Muv) phenotype due to theectopic
expression of vulval cell fates by P3.p, P4.p, and P8.p.In this paper, we have examined how LIN-31 WH and
LIN-1 Ets control vulval development in response to We observed that a lin-31(n1053); mpk-1(ga117) double
mutant exhibited a Muv phenotype similar to that exhib-MAP kinase signaling. Our results suggest that LIN-31
and LIN-1 are direct targets of MAP kinase and that LIN- ited by lin-31 single mutants. These results show that
lin-31 mutations can cause vulval induction indepen-31 and LIN-1 physically interact with each other only
when they areunphosphorylated. We propose that when dently of mpk-1 activity, suggesting that lin-31 WHeither
acts downstream of mpk-1 or in a parallel pathway toMAP kinase is inactive, unphosphorylated LIN-31 and
LIN-1 form a protein complex that inhibits vulval fates. mpk-1. Recently, similar results have also been obtained
with lin-1 (M. R. L. and S. K. K., unpublished data).Upon MAP kinase phosphorylation, the LIN-31/LIN-1
complex is disrupted, and phosphorylated LIN-31 pro-
motes vulval fates. LIN-31 WH and LIN-1 Ets Are Phosphorylated
by MAP KinaseFurthermore, we show that LIN-31 mediates MAP ki-
nase signaling in the vulval precursor cells and is not The results presented above and in M. R. L. and S. K. K.
(unpublished data) suggest that both LIN-31 WH andlikely to do so in other tissues where MAP kinase signal-
ing is known to function. Thus, LIN-31 WH seems to act LIN-1 Ets may act as direct targets of MPK-1 during
vulval induction. Indeed, LIN-31 possesses four consen-as a tissue-specific effector of a generally used signaling
pathway. The physical interaction of tissue-specific ef- sus MAP kinase phosphorylation sites (S/T-P), and LIN-1
contains 18 consensus MAP kinase sites (Clark-Lewisfectors (such as LIN-31 WH) with general effectors (such
as LIN-1 Ets) may allow different genes in different tis- et al., 1991). To determine whether MAP kinase can
directly phosphorylate LIN-31 or LIN-1, we performedsues to be controlled by similar upstream signals, and
it may permit common signaling pathways to trigger in vitro phosphorylation experiments by incubating acti-
vated rat ERK2 with purified GST-LIN-31 or epitope-distinct developmental programs and cell fate choices.
tagged FLAG-LIN-1. As rat ERK2 can functionally rescue
the mpk-1 mutant phenotype in transformation experi-Results
ments (Wu and Han, 1994), it is likely that rat ERK2 can
recognize the substrates that are normally phosphory-lin-31 WH Acts Downstream of mpk-1
We analyzed the phenotype of a lin-31 mpk-1 double lated by C. elegans MPK-1. We found that both GST-
LIN-31 and FLAG-LIN-1 were efficiently phosphorylatedmutant to determine whether lin-31 WH acts down-
stream of mpk-1 (Figure 1). mpk-1(null) mutants have a by ERK2 in vitro (Figures 2A and 2B). We then used
LIN-1 and LIN-31 Mediate MAP Kinase Signaling
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Figure 2. LIN-31 and LIN-1 Are Phosphory-
lated by MAP Kinase In Vitro and In Vivo
(A) In vitro phosphorylation of LIN-31 by MAP
kinase. GST-LIN-31 proteins possessing all 4
MAP kinase phosphorylation sites (lane 2),
three sites, T145M (lane 3), or no sites,
T145M, T200A, T218A, T220A (lane 4) were
incubated with 32P g-ATP and activated rat
ERK2. The top figure indicates the relative
amount of 32P g-ATP incorporated into the
test substrate. The bottom figure is a loading
control, showing the same blot stained with
a-LIN-31 antibodies. Quantitative analysis
using a phosphoimager indicates that the
amount of incorporation in lane 3 is approxi-
mately 50% that of lane 2. LIN-31 is phos-
phorylated 25% as well as the reference sub-
strate Myelin Basic Protein (P. B. T., data not
shown).
(B) In vitro phosphorylation of FLAG-LIN-1
by MAP kinase. Epitope-tagged FLAG-LIN-1
protein was incubated with ATP in the ab-
sence or presence of activated ERK2. Pro-
teins were separated on a 9% SDS-PAGE gel,
blotted, and probed with a-FLAG antibodies.
Phosphorylated FLAG-LIN-1 appears as a slower migrating band on SDS-PAGE (left). Treatment with l phosphatase (NEB) confirms that the
slower migration is due to phosphorylation (right).
(C) Stimulation of NIH 3T3 cells by activated H-Ras (lanes 2 and 4) or activated MEK1 (lanes 6 and 8) causes a retardation in electrotrophoretic
mobility (LIN-31-P) of HA LIN-31 but not HA-LIN-31(PhD). AM* (lanes 6 and 8) is a proteolytic product of the activated MEK1 construct (which
also possesses a HA epitope tag) and is seen in cells transfected with activated MEK1 alone.
(D) Stimulation of NIH 3T3 cells by activated H-Ras (lane 2) or activated MEK1 (lane 4) causes a mobility retardation (LIN-1-P) in FLAG-LIN-1.
site-directed mutagenesis to generate LIN-31(PhD) (for LIN-31 WH Binds to LIN-1 Ets
lin-31 and lin-1 behave similarly in a number of ways:Phosphorylation Defective), in which all four LIN-31 con-
sensus MAP kinase phosphorylation sites werereplaced mutations in both genes cause Muv phenotypes, both
genes act downstream of mpk-1, and LIN-31 WH andby nonphosphorylatable amino acids (see Experimental
Procedures). We found that ERK2 was unable to phos- LIN-1 Ets are both likely to be substrates for MAP ki-
nase. Based upon these similarities, we decided to testphorylate GST-LIN-31(PhD) (Figure 2A, lane 4), indicat-
ing that ERK2 phosphorylates LIN-31(1) on some or all whether LIN-31 WH and LIN-1 Ets might physically in-
teract.of the four consensus sites of LIN-31 in vitro.
To determine whether MAP kinase might phosphory- To determine whether LIN-31 binds to LIN-1 in vivo,
we coinfected insect Sf9 cells with recombinant baculo-late LIN-31 and LIN-1 in vivo, NIH 3T3 fibroblasts were
transfected with vectors expressing either epitope- viruses encoding GST-LIN-31 and epitope-tagged FLAG-
LIN-1. GST-LIN-31 protein was then purified from whole-tagged versions of LIN-31, nonphosphorylatable LIN-
31(PhD), or LIN-1. These cells were then stimulated by cell lysates, and the presence of FLAG-LIN-1 in the
GST-LIN-31 complex was determined using a-FLAG anti-cotransfecting them with vectors expressing either con-
stitutively activated H-Ras (G12V) or constitutively acti- bodies in Western blotting experiments. This experiment
revealed that FLAG-LIN-1 associated with GST-LIN-31vated MEK1 (DN3, S222D). Both activated proteins have
previously been shown to stimulate MAP kinase (ERK1 (Figure 3A) but not with theDrosophila USP transcription
factor (GST-USP), indicating that the association ofand ERK2) activity in vivo (Leevers and Marshall, 1992;
Mansour et al., 1994), and in particular, MEK1 is believed LIN-1 with LIN-31 is specific. We also performed this
experiment in reverse and found that LIN-31 specificallyto act as a highly specific activator of ERK1 and ERK2
(Robbins et al., 1993). Stimulation by activated H-Ras coimmunprecipitated with LIN-1 (data not shown). These
results show that LIN-1 specifically copurifies with LIN-or activated MEK1 caused a substantial portion of LIN-
31 protein to display a reduced electrophoretic mobility 31 when coexpressed in insect cells.
To determine whether LIN-31 can directly bind toon SDS-PAGE gels (Figure 2C). This mobility shift was
not seen in cells expressing LIN-31(PhD), suggesting LIN-1, we performed in vitro binding experiments using
independently purified GST-LIN-31 and FLAG-LIN-1. Asthat it is most likely due to phosphorylation. Similarly,
stimulation by activated H-Ras or activated MEK1 caused seen in Figure 3B, FLAG-LIN-1 bound to GST-LIN-31 in
vitro. We then defined the region of LIN-31 that containsLIN-1 to migrate as a slower and more compact band on
SDS-PAGE gels (Figure 2D), similar to the shift observed the LIN-1±binding site. GST-LIN-31 fusion proteins con-
taining the LIN-31 DNA-binding domain, the middle re-when LIN-1 is phosphorylated by MAP kinase in vitro.
These results indicate that both LIN-31 and LIN-1 are gion of LIN-31, and the C terminus of LIN-31 were made
in bacteria and tested for their ability to bind to FLAG-likely to be phosphorylated by the MAP kinases ERK1
or ERK2 in NIH 3T3 cells. LIN-1 in vitro (Figure 3B). The middle region (amino acids
Cell
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Figure 3. LIN-1 Binding to LIN-31 Is Inhibited by MAP Kinase
(A) LIN-1 binds to LIN-31 in vivo. GST-LIN-31 was purified from Sf9 cells coexpressing GST-LIN-31 and FLAG-LIN-1. FLAG-LIN-1 (arrow)
associated with GST-LIN-31 and not with GST-USP. Equal amounts of FLAG-LIN-1 and GST-fusion protein were produced in both lysates
(left and data not shown).
(B) LIN-1 and LIN-31 directly interact in vitro. Overlapping regions of LIN-31 (regions A [aa 1-39], B [aa 39-169], and C [aa 169-237]) were
tested for their ability to bind FLAG-LIN-1 using a-FLAG antibodies in Western blotting experiments (right gel). Only full-length GST-LIN-31
protein and GST-B (aa 39-169) bound to FLAG-LIN-1. FLAG-LIN-1 did not bind to GST-A, GST-C, or the negative control GST-LIN-7.
(C) Inhibition of LIN-1 and LIN-31 interaction by MAP kinase. GST-LIN-31 and FLAG-LIN-1 were independently purified and then coincubated
in the presence or absence of rat ERK2 and ATP. Both proteins were mixed, and GST-LIN-31 was subsequently isolated. FLAG-LIN-1 was
detected using a-FLAG antibodies on Western blots and was only seen to associate with GST-LIN-31 when MAP kinase was absent from the
reaction mix.
(D and E) Phosphorylation of LIN-31 inhibits binding to LIN-1. (D) Unphosphorylated FLAG-LIN-1 binds to unphosphorylated GST-LIN-31 but
not prephosphorylated GST-LIN-31-P (prepared by preincubation with ERK2). (E) In the reciprocal experiment, unphosphorylated GST-LIN-
31 binds to both prephosphorylated and unphosphorylated FLAG-LIN-1.
(A±E) Gels on the left are fusion protein loading controls, showing that equivalent levels of bait protein were used. 10% inp. indicates 10%
of the total float protein present in the extract before binding.
39-169) bound to FLAG-LIN-1 as well as full-length GST- MAP Kinase Phosphorylation Disrupts Formation
of the LIN-1/LIN-31 ComplexLIN-31. However, the DNA-binding domain, the C termi-
nus, and the negative control GST-LIN-7 did not bind To test whether MAP kinase might regulate the activity
of LIN-31 WH and LIN-1 Ets by affecting their bindingto FLAG-LIN-1 under the same binding conditions. Inter-
estingly, this 130 amino acid middle region of LIN-31 that interaction, purified GST-LIN-31 and FLAG-LIN-1 proteins
were incubated together in the presence of activatedbinds LIN-1 also contains a MAP kinase phosphorylation
site (Thr-145) and may be a transcriptional activation MAP kinase and ATP. Phosphorylated GST-LIN-31 was
recovered and assayed for bound phosphorylated FLAG-domain, since it is acidic and proline-rich.
LIN-1 and LIN-31 Mediate MAP Kinase Signaling
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Figure 4. Vulval Phenotypes Caused by LIN-1::LIN-31, LIN-31(PhD), and LIN-31(VP16)
(A±D) Vulval induction is normal in animals that express lin-31(1) (A) or lin-1(1) transgenes (Table 1). Expression of the lin-1::lin-31 forced
heterodimer (B) or lin-31(PhD) (C) blocks vulval induction. Expression of a lin-31(VP16) promotes vulval induction (D). White lines indicate
hypodermal cells derived from Pn.p cells that have adopted nonvulval 38 or U cell fates rather than vulval 18 or 28 cell fates. White arrows
indicate cells derived from Pn.p cells that have expressed vulval 18 or 28 cell fates. The exact vulval cell lineages of the animals in (B) and (C)
are shown in Table 2 (animal B3 and C5). Scale bar is 10 mm for (A±C) and 25 mm for (D).
LIN-1. This experiment revealed that MAP kinase phos- LIN-1/LIN-31 inhibitor complex, phosphorylated LIN-31
could also actively promote the expression of vulval cellphorylation substantially reduced the amount of FLAG-
LIN-1 bound to GST-LIN-31 in vitro (Figure 3C). fates. This is because lin-31 loss-of-function mutants
also exhibit a partial Vul phenotype (indicating a functionWe then determined whether MAP kinase phosphory-
lation of either factor alone was sufficient to prevent in promoting vulval cell fates). In the following sections,
we use three different lin-31 constructs to test predic-formation of the LIN-1/LIN-31 complex. Phosphorylated
GST-LIN-31 and FLAG-LIN-1 were generated indepen- tions of this model.
If the LIN-1/LIN-31 complex inhibits vulval induction,dently by preincubating each purified protein with MAP
kinase. Phosphorylated GST-LIN-31 was then bound to then maintaining this complex in each of the vulval pre-
cursor cells should result in constitutive vulval inhibition.glutathione beads, and phosphorylated FLAG-LIN-1 was
bound to a-FLAG beads. Bound phosphorylated protein To test this prediction, we constructed a LIN-1/LIN-31
forced heterodimer by engineering a transgenethat useswas mixed with its unphosphorylated partner (phos-
phorylated GST-LIN-31 with unphosphorylated FLAG- the lin-31 promoter to express a single polypeptide con-
taining the entire lin-1 coding sequence followed by theLIN-1, and vice versa), and binding between the two
proteins was assayed. Phosphorylation of LIN-31, but entire lin-31 coding sequence (termed LIN-1::LIN-31).
not LIN-1, disrupted formation of the LIN-1/LIN-31 com-
plex. Specifically, we found that phosphorylated LIN-31
Table 1. Vulval Phenotypes of Modified lin-31 Transgenesdid not bind to unphosphorylated LIN-1 (Figure 3D), but
phosphorylated LIN-1 still bound to unphosphorylated Percent
LIN-31 (Figure 3E). Thus, phosphorylation of LIN-31 by
Transgene lin-31 Genotype Muva Egl/Vula No.bMAP kinase is sufficient to prevent the association of
Ð WT 0 0 ManyLIN-31 and LIN-1 in vitro.
lin-31(1) WT 0 4 6 2 .200
lin-1 (1) WT 0 3 6 3 156A LIN-1/LIN-31 Forced Heterodimer Inhibits
lin-1::lin-31 WT 0 50 6 7 187Vulval Cell Fates lin-31(PhD) WT 0 42 6 7 194
These biochemical results suggest a model of how MAP lin-31(DBR) WT 5 6 7 20 6 5 188c
kinase activity could control the activity of LIN-31 WH lin-31(VP16) WT 33 6 6 5 6 3 162c
and LIN-1 Ets in the vulval precursor cells. In vulval Ð lin-31(n1053) 61 40 Many
precursor cells where MAP kinase is inactive (P3.p, P4.p, lin-31(1) lin-31(n1053) 12 6 4 10 6 3 .250
and P8.p), unphosphorylated LIN-1 and LIN-31 form a lin-1::lin-31 lin-31(n1053) 23 6 6 77 6 6 173
lin-31PhD) lin-31(n1053) 10 6 4 62 6 7 202complex that inhibits the expression of vulval cell fates.
lin-31(VP16) lin-31(n1053) 87 6 4 ND 195Mutations in lin-31 or lin-1 would lead to a failure of this
inhibition, and as a result these cells would ectopically a Numbers indicate the mean 6 95% confidence interval.
b No. of animals scored.express vulval cell fates. In vulval precursor cells where
c rol-61 was used as a transgenic marker. All other strains wereMAP kinase is active (P6.p and possibly P5.p and P7.p),
generated using unc-291.MAP kinase phosphorylation would disrupt this complex
ND, not determined.
and alleviate vulval inhibition. In addition to loss of the
Cell
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A Nonphosphorylatable LIN-31 ProteinTable 2. Vulval Lineages in Animals Expressing lin-31
Inhibits Vulval Cell FatesTransgenes
Since phosphorylation of LIN-31 (but not LIN-1) is suffi-
Genotype P3.p P4.p P5.p P6.p P7.p P8.p
cient to disrupt the LIN-1/LIN-31 complex, another pre-
A. N2 SS or U SS LLTN TTTT NTLL SS diction is that an unphosphorylatable form of LIN-31
38 38 28 18 28 38 (such as LIN-31[PhD]) should remain complexed with
LIN-1 and thus function as a constitutive inhibitor of
B. lin-31 (1); Ex [lin-1::lin-31] vulval induction. We microinjected lin-31(PhD) DNA into
U 38 38 18 38 38/U lin-31(1) animals, obtained three transgenic lines, and
U 38 38 TTN 38 38 found that an average of 42% of animals exhibited a
U/38 38 38 38 38 38 dominant Vul phenotype (Figure 4C and Table 1). We
U 38 U 38 38 38 then directly determined the pattern of cell fates ex-
U U 38 18 38 38
pressed by P5.p, P6.p, and P7.p in these animals and
again found that these cells often adopted uninduced
C. lin-31 (1); Ex[lin-1(PhD)]
or defective cell fates (Table 2). These results suggest
38 38 28 18 28 38 that LIN-31(PhD) can act to diminish the mpk-1 signaling
U 38 38 LOTT 28 38
pathway in the vulva, perhaps by remaining complexed
38 38 28 18 38 38
with LIN-1.
U 38 U LLNT 38 38
We also microinjected DNA containing lin-31(PhD)U 38 38 18 U 38
into lin-31(null) worms and found that lin-31(PhD) could
rescue the Muv but not the Vul phenotype of lin-31 nullD. lin-31 (n1053); Ex[lin-31(PhD)]
mutants (out of five independent transgenic lines) (Table
38 38 38 LTN U 38 1). We determined the cell lineages expressed by the
U U NTLL 18 38 38 vulval precursor cells in one of the transgenic lines ex-
38 38 NTLL 18 38 38
pressing LIN-31(PhD) (Table 2). In these animals, P3.p,
U 3 LLTN TLN 38 38
P4.p, and P8.p expressed the nonvulval 38 cell fate (as in
U 38 38 TON 38 38
wild-type), suggesting that lin-31(PhD) can inhibit vulval
Wild-type vulval lineages are indicated in (A) with the following ab- induction. However, P5.p, P6.p, and P7.p often ex-
breviations: L, longitudinal division (underlining indicates adherence pressed partial vulval cell fates or the 38 nonvulval cell
to the ventral cuticle); O, oblique division; T, transverse division; N, fates (instead of the 18 and 28 cell fates), suggesting
Pn.px division did not occur; U, Pn.p cell did not divide to give
that lin-31(PhD) does not function to promote vulvalprogeny; S, Pn.px fused with syncitial hypodermis. 18 5 TTTT, 28 5
induction.LLTN or NTLL, and 38 5 SS or U (for P3.p). Inappropriate or defective
lineages are boxed. Lineages designated 38/U could not be unam-
biguously determined a 38 or U. All animals were lineaged at 208C.
LIN-31(VP16) Promotes Vulval Cell Fates
In addition to inhibiting vulval cell fates in P3.p, P4.p,
and P8.p, genetic analysis suggests that LIN-31 WHAlthough our biochemical studies indicate that phos-
phorylation greatly reduces LIN-1/LIN-31 binding, some promotes the expression of vulval fates in P5.p, P6.p,
and P7.p. MPK-1 is active in P6.p (and possibly P5.pbinding is still observed at high protein concentrations
(P. B. T., unpublished observations). The close proximity and P7.p as well), suggesting that LIN-31 may be phos-
phorylated in these cells. How might phosphorylationof LIN-1 and LIN-31 sequences in the forced hetero-
dimer might permit binding interactions to occur even of LIN-31 allow it to promote vulval induction? In many
cases, the phosphorylation of a transcription factor by awhen these proteins are phosphorylated. We injected
this construct into lin-31(1); lin-1(1) animals, obtained MAP kinase creates or reveals a potent trans-activation
domain (Treisman, 1996). This might also be the casesix transgenic lines, and observed that 10%±50% of the
transgenic animals exhibited a dominant Vul phenotype for LIN-31 WH, especially since the middle region of
LIN-31 that contains the LIN-1±binding site also contains(Figure 4B and Table 1). In contrast, transgenic lines
that expressed either lin-31 or lin-1 alone did not exhibit a putative LIN-31 trans-activation domain and a MPK-1
phosphorylation site. To pursue this possibility, we re-this effect, indicating that the vulvaless phenotype of
LIN-1::LIN-31 animals is not likely to be due to overex- placed both the phosphorylation domain and the LIN-
1±binding region of LIN-31 with a strong trans-activationpression of either lin-31 or lin-1 (Figure 4A and Table 1).
We then used Nomarski microscopy to determine the domain (VP16), reasoning that this might be functionally
analogous to constitutive phosphorylation by MPK-1.pattern of vulval precursor cell division in animals ex-
pressing LIN-1::LIN-31. We observed that in these ani- We injected DNA containing lin-31(VP16) into lin-31(1)
animals, generated four transgenic lines, and found thatmals, P5.p, P6.p, and P7.p (which normally express 18
or 28 vulval fates) often expressed nonvulval 38 cell fates 10%±30% of the animals from these transgenic lines
exhibited a dominant Muv phenotype (Figure 4D). As a(Table 2). These lineage patterns are similar to the phe-
notype caused by mutations that diminish the activity control, we also engineered a construct that expressed
only the DNA-binding region of LIN-31, introduced thisof the vulval signaling pathway, such as mutations in
lin-3 EGF, let-23 receptor, let-60 Ras, or mpk-1 (Korn- construct into lin-31(1) mutants, and generated five
transgenic lines. We found that expression of the LIN-feld, 1997). Thus, these results suggest that preventing
dissociation of LIN-1 from LIN-31 blocks vulval in- 31 DNA-binding region alone didnot result ina dominant
Muv phenotype (Table 1), indicating that the effects ofduction.
LIN-1 and LIN-31 Mediate MAP Kinase Signaling
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Figure 5. LIN-31 Expression Patterns
Green, a-LIN-31 staining; red, MH27 staining; blue, DAPI staining.
(A) Expression pattern of LIN-31 in wild-type animals at the L2 stage. LIN-31 is expressed in the Pn.p cells (P1.p±P11.p), including the vulval
precursor cells (P3.p±P8.p). MH27 stains the cell junctions of P3.p±P8.p at this stage.
(B) LIN-31 expression is not observed in lin-31(ga37) or in lin-31(n1053) animals (P. B. T., unpublished observations).
(C) DAPI staining at the L4 stage shows the gonad (large arrows). (D) LIN-31 is expressed in the vulval precursor cell descendants (arrows)
but not in the gonad or sex myoblasts, which flank the P6.p progeny during this time.
(E) At the L1 larval stage, LIN-31 is not expressed in the excretory duct cell (exc) or in P12.p but is expressed in P1.p to P11.p.
(F) At this same stage, let-23(mn23) mutants arrest in development indicating prior function of this signaling pathway in cells comprising the
excretory system.
(G) In males 25 hr after hatching, LIN-31 is expressed in 3 of the 4 B cell progeny (B.a[l or r]pp, B.alap, B.arap, but not B.a[l or r]aa) that utilize
LET-23 RTK signaling. Green indicates nuclei expressing LIN-31 located in the sagital ventral midline (same plane as MH27 staining), while
blue indicates nuclei expressing LIN-31 located laterally left of the midline. Other cells expressing LIN-31 during the L2/L3 stage in the
hermaphrodite include the excretory duct cell (exc) and the neuronal cell T.ppa (known as PVWL/R). Scale bar for (A±G) is 10 mm.
lin-31(VP16) are not due to the DNA-binding domain of performed immunocytochemistry experiments to deter-
mine the LIN-31 expression pattern. LIN-31 is first ex-LIN-31 acting as a dominant-negative protein. In addi-
tion, we also injected DNA containing lin-31(VP16) into pressed in the nuclei of P1.p±P11.p (including the vulval
precursor cells), from the middle of the first larval (L1)lin-31(null) animals and obtained three transgenic lines.
The penetrance of the Muv phenotype in these trans- stage until the early L3 stage (Figure 5A). Since activation
of MPK-1 is thought to occur during this time (Kimble,genic lines is significantly higher than that of lin-31 null
mutants (Table 1), again suggesting that LIN-31(VP16) 1981; Euling and Ambros, 1996), these results show that
LIN-31 is present in the vulval precursor cells at thepromotes the expression of vulval cell fates.
Taken together, these results indicate that LIN-31(VP16) appropriate time and place to respond to activated
MPK-1.causes the vulval precursor cells to express vulval cell
The mpk-1 signaling pathway is used in the vulva, thefates. The simplest interpretation of these results is that
germline, and the sex myoblasts (Church et al., 1995;LIN-31(VP16) is functionally analogous to phosphory-
Sundaram et al., 1996; M. R. L. and S. K. K., unpublishedlated LIN-31 WH, since both proteins do not associate
data). Inaddition, mpk-1 mutations cause L1 larval lethalitywith LIN-1 and both may act as transcriptional acti-
and male spicule defects that appear to be identical tovators.
the phenotypes caused by let-23 receptor and let-60
Ras loss-of-function mutations (M. R. L. and S. K. K.,
unpublished data). These let-23 receptor and let-60 RasLIN-31 WH Is Expressed in the Vulval Precursor
Cells but Is Absent from Many Other phenotypes are caused by defects in the excretory sys-
tem and in the male B cell lineage (Chamberlin andmpk-1 Responsive Tissues
To test whether LIN-31 WH is expressed at the appro- Sternberg, 1994; Koga and Ohshima, 1995; Yochem et
al., 1997), suggesting that mpk-1 acts in these cells aspriate time and place to be a substrate for MPK-1, we
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well. Finally, the let-23 receptor signaling pathway also
acts to establish the fate of P12 in the posterior ecto-
derm (Aroian and Sternberg, 1991; P. Sternberg, per-
sonal communication), and mpk-1 may function in this
cell as well.
Two pieces of evidence suggest that lin-31 interacts
with the mpk-1 signaling pathway only in the vulva and
not in other tissues. First, LIN-31 protein is expressed
primarily in the vulval precursor cells and not in these
other tissues. We did not detect LIN-31 expression in
the germline, P12 (the posterior ectoderm), and the sex
myoblasts (Figures 5C±5E, data not shown). LIN-31 is
also not expressed in the excretory system at the appro-
priate time to respond to mpk-1 signaling. mpk-1 signal-
ing in the excretory system probably occurs before or
during the mid L1 larval stage, as larval lethality caused
by loss-of-function mutations in the let-23 signaling
pathway occurs at this time (Aroian and Sternberg, 1991;
Yochem et al., 1997; M. R. L. and S. K. K., unpublished
data). We then determined the LIN-31 expression pat-
tern in wild-type animals at the same developmental
stage as arrested let-23 mutant larvae, and we found
that LIN-31 is not expressed in the excretory duct cell
of wild-type animals at this stage (Figures 5E and 5F).
Intriguingly, we observed LIN-31 expression in this cell
later, in the mid L2 stage (Figure 5A).
Second, lin-31 and mpk-1 exhibit similar mutant phe-
notypes only in vulval induction. Specifically, lin-31 mu-
tants exhibit defects in vulval cell fate specification but
do not exhibit apparent phenotypes in the excretory
system, sex myoblasts, germline, or posterior ectoderm
(Miller et al., 1993; Sundaram et al., 1996; P. B. T., unpub-
lished observations).
In addition to its role in vulval development, lin-31
functions in the development of the male tail. However,
the function of lin-31 in this tissue is likely to be different
from that of the mpk-1 signaling pathway. The mpk-1
signaling pathway is thought to act in the male tail to
specify the fate of four cells that arise from the B cell
lineage (B.a[l or r]pp, B.alap, B.arap, and B.a[l or r]aa)
(Chamberlin and Sternberg, 1994). LIN-31 is expressed
in three of these four cells (all except B.a[l or r]aa) (Figure
5G). However, the lin-31 male tail phenotype is distinctly
different from the let-23 receptor and let-60 Ras mutant
phenotype (S. Baird, personal communication). The de-
fective mating spicules of lin-31 males result from the
Figure 6. Ectopic Expression of lin-31 in P12 Causes Induction ofabnormal migration of cells in the tail proctodeum (B.al/
a Vulval-Specific Markerrappv and B.al/rapapa), a process that occurs two (B.al/
(A) P6.p exhibits increased LET-23 RTK expression in wild-typerappv) or three (B.al/rapapa) cell divisions later than the
animals (100% of animals, n 5 50).
cell fate specification defects of let-23 receptor or let- (B) In a lin-31(n1053) mutant, increased expression of LET-23 RTK
60 Ras mutants. These results suggest that lin-31 may is observed in only 46% of animals (n 5 50).
(C) Increased LET-23 RTK expression is not observed in P12 in anot interact with the mpk-1 signaling pathway in the
wild-type L1 animal (5 hr after hatching, n 5 15).male tail to specify the fates of the B cell progeny. One
(D) Ectopic expression of LIN-31 in P12 from a heat-shock promoterpossibility is that LIN-31 is not expressed in these cells
results in increased expression of LET-23 RTK in P12 in 33% of
when MPK-1 is activated but is only expressed after observed animals (n 5 12). Increased LET-23 RTK expression was
MPK-1 signaling has finished. Determining when MPK-1 not observed in heat-shocked controls that did not carry the hs-lin-
signaling occurs in this tissue will help to resolve this 31 transgene (n 5 20, data not shown). Scale bar is 10 mm.
issue.
In summary, these genetic and expression studies
suggest that lin-31 does not interact with the mpk-1 most likely does not interact with this pathway in male
signaling pathway in the germline, the posterior ecto- tail development to specify the fates of the B cell prog-
eny. LIN-31 WH may thus act as a vulval-specific effectorderm, the sex myoblasts, or the excretory system and
LIN-1 and LIN-31 Mediate MAP Kinase Signaling
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of mpk-1 signaling and contribute to the signaling speci-
ficity of the MPK-1 signaling pathway.
Ectopic Expression of LIN-31 Causes P12
to Express a Vulval-Specific Marker
We wanted to determine whether ectopic expression of
LIN-31 in another let-23 receptor±responsive cell type
might partially induce that cell to express vulval-specific
markers in response to let-23 signaling. One such
marker is increased LET-23 RTK expression, since stain-
ing with a-LET-23 antibodies shows that LET-23 RTK
expression sharply increases in P6.p (Figure 6A; Simske
et al., 1996). This feedback regulation is thought to be
important for vulval patterning, as high LET-23 RTK lev-
els may bind and sequester LIN-3 and thereby prevent
LIN-3 from inducing other vulval precursor cells (Hajnal
et al., 1997). Increased expression of LET-23 RTK is a
vulval-specific event, because LET-23 RTK expression
does not increase in the P12 posterior ectoblast, when
the let-23 signaling pathway functions to specify the
P12 fate (Figure 6C).
We found that lin-31 is required to increase LET-23
RTK expression in P6.p. In lin-31 null mutants, we de-
tected increased LET-23 RTK expression in P6.p in only
46% of lin-31 null mutants (n 5 50) versus 100% of
wild-type animals (n 5 50) (Figure 6B). Thus, lin-31 is
necessary for the accurate and fidelitous execution of
positive LET-23 RTK expression in P6.p.
Next, we tested whether ectopic expression of lin-31
in P12 could cause it to express this vulval specific
marker. A heat-shock promoter was used to ectopically
express LIN-31 in P12 during the time of P12 specifica-
tion. We detected increased LET-23 RTK expression in
P12 in 33% of heat-shocked animals (n 5 12) but no
increased expression in any wild-type (n 5 15) or heat-
shocked control animals (n 5 20) (Figure 6D). These
results demonstrate that lin-31 functions as a vulval-
specific effector of let-23 signaling, as lin-31 misexpres-
sion causes a heterologous let-23 responsive cell to
express a vulval-specific marker (increased LET-23 RTK
expression).
Discussion Figure 7. Models for LIN-31 Function in Vulval Development and as
a Tissue-Specific Effector of MAP Kinase Signaling
The LIN-31 WH and LIN-1 Ets transcription factors act as (A) LIN-31 function in vulval development. In cells where MAP kinase
is inactive (P3.p, P4.p, and P8.p), the LIN-1/LIN-31 complex inhibitsdirect targets of MAP kinase to control vulval induction.
vulval induction. Conversely, in P6.p (and possibly P5.p and P7.p)Both lin-31 and lin-1 function downstream of mpk-1 (this
where MAP kinase is active, LIN-1 and LIN-31 dissociate, and phos-report, M. R. L. and S. K. K., unpublished data), and both
phorylated LIN-31 promotes vulval induction. In a lin-31 loss-of-
factors can be phosphorylated by MAP kinase in vitro function mutant, LIN-31 target genes fail to be either actively re-
and in vivo in NIH 3T3 cells. Furthermore, unphosphory- pressed or activated. Arrows and inhibitory bars reflect genetic
lated LIN-31 WH and LIN-1 Ets directly bind to each activities and may not necessarily indicate direct transcriptional
activation or repression. For example, the LIN-31/LIN-1 complexother in vitro and invivo, and this interaction is prevented
may act as a vulval inhibitor complex by transcriptionally activatingby MAP kinase phosphorylation of LIN-31 in vitro.
the expression of a vulval repressor gene.These observations suggest the following model for
(B) LIN-31 is a tissue-specific effector of MAP kinase signaling. The
how MAP kinase might regulate LIN-31 and LIN-1 during Ras/MAP kinase signaling pathway is used in the development of
vulval development (Figure 7A). In vulval precursor cells at least six distinct tissues in the nematode. LIN-31 may transduce
where MAP kinase is inactive (P3.p, P4.p, and P8.p), the mpk-1 signal specifically in the vulva, while LIN-1 may act as a
more general effector of this signaling pathway. In addition, regionalLIN-31 and LIN-1 areassociated as a complex that inhib-
expression of Hox genes may also impart specificity to this signalingits vulval induction, resulting in these vulval precursor
pathway (Maloof and Kenyon, 1998).cells expressing the nonvulval 38 cell fate. Since the LIN-
1±binding site on LIN-31 overlaps a possible transcrip-
tional activation domain, LIN-1 binding to LIN-31 may
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mask the LIN-31 trans-activation domain and prevent critical for vulval induction, and phosphorylation of LIN-
LIN-31 from functioning as a transcriptional activator. 31 alone may be sufficient to inactivate LIN-1 by dis-
Activation of MAP kinase in P6.p (and possibly P5.p and rupting the LIN-1/LIN-31 inhibitor complex.
P7.p) by the let-23 receptor signaling pathway results
in the phosphorylation of LIN-31 and LIN-1, causing
Positive and Negative Regulation of Vulvaldissociation of the LIN-1/LIN-31 complex. Once dissoci-
Cell Fatesated from LIN-1, phosphorylated LIN-31 may then act
How does this proposed model explain the deregulatedas a transcriptional activator to promote the expression
vulval phenotype of lin-31 null mutants? One simpleof vulval fates. In addition, MAP kinase phosphorylation
explanation would be that in lin-31(null) animals, down-of LIN-31 at Thr-145 may also potentiate the trans-acti-
stream vulval specification genes normally regulated byvation region of LIN-31.
We tested this model in three ways. First, if LIN-1 and lin-31(1) would fail to be either strongly activated or
LIN-31 form a complex in vivo that functions to inhibit inhibited (Figure 7A). Instead, these genes would be
vulval induction, then a strain in which LIN-1 is always transcribed at an intermediate or basal level, which
associated with LIN-31 should be Vul. We engineered a might also be near the threshold for vulval induction.
gene that expresses a LIN-1::LIN-31 forced heterodimer, Consequently, stochastic variation in the expression lev-
similar to that reported for the bHLH factors MyoD and els of these LIN-31 target genes would eventually cause
E47 (Neuhold and Wold, 1993). Such a LIN-1::LIN-31 some vulval precursor cells to express vulval cell fates.
fusion protein might maintain high local concentrations In lin-31 mutants, the vulval precursor cells do not
of both the LIN-31 and LIN-1 fragments and associate adopt a uniform hybrid fate that might result from the
intramolecularly even when phosphorylated by MPK-1. uniform basal transcription of downstream specification
We found that the lin-1::lin-31 transgene caused a partial genes (the LIN-31 targets). Instead, the vulval precursor
dominant vulvalessphenotype, indicating that LIN-1 and cells typically express discrete cell fates (18, 28, or 38).
LIN-31 most likely associate as a vulval inhibitor com- This observation suggests that in lin-31 mutants initial
plex in vivo. small stochastic differences in the transcription of LIN-
Second, a nonphosphorylatable form of LIN-31 (LIN- 31 target genes from cell to cell and from animal to
31[PhD]) also caused a partial dominant vulvaless phe- animal are ultimately translated into large differences in
notype, suggesting that preventing LIN-31 phosphoryla- the expression of terminal cell fates (i.e., 18, 28, or 38).
tion also causes the LIN-1/LIN-31 heterodimer to persist We speculate that this might occur through a system
in vivo. Furthermore, lin-31(PhD) rescues the Muv phe- of positive and negative autoregulatory feedback; spe-
notype of lin-31 null mutants, indicating that LIN-31(PhD) cifically, the products of these LIN-31 target genes might
can function to inhibit vulval induction in P3.p, P4.p, and positively regulate their own expression and negatively
P8.p. In these cells in wild-type animals, MAP kinase is cross-regulate genes promoting the alternative cell fate
most likely inactive, and LIN-31(1) ismost likely unphos- (Miller et al., 1993). In this model, if these postulated
phorylated. Thus, LIN-31(PhD) retains the function asso- LIN-31 target genes were initially expressed above a
ciated with unphosphorylated LIN-31(1). However, lin-
certain threshold, then these feedback loops could am-
31(PhD) does not rescue the Vul phenotype of a lin-31
plify their own expression and cause thevulval precursor
null mutant, indicating that LIN-31(PhD) does not retain
cell to adopt a discrete 18 or 28 cell fate. If the initial
the function associated with phosphorylated LIN-31 (in
level were lower than a certain threshold, then theseP6.p and possibly P5.p and P7.p). These results suggest
feedback loops would not be maintained and such athat LIN-31 is phosphorylated in vivo and that this phos-
vulval precursor cell would express the 38 cell fate. Simi-phorylation determines whether vulval precursor cells
lar mechanisms have been proposed to explain howexpress vulval or nonvulval cell fates.
small qualitative differences can be amplified to yieldThird, if MAP kinase phosphorylation results in disso-
distinct biological responses in the life cycle of phageciation of the LIN-1/LIN-31 inhibitor complex and acti-
l and in the process of Drosophila sex determinationvates a LIN-31 trans-activation domain, then replacing
(Ptashne et al., 1980; Bell et al., 1991).the LIN-1 binding region of LIN-31 with the VP16 trans-
A key implication of this model is that in wild-typeactivation domain should be functionally analogous to
animals, LIN-31 target genes are either strongly activatedconstitutive LIN-31 phosphorylation. This is because the
or repressed. Recent reports suggest that many diverseVP16 trans-activation domain should not bind to LIN-1
transcription factors (such as Mad, CREB, c-Jun, NF-and should function as a trans-activation domain inde-
kB, and the various nuclear hormone receptors) canpendently of MAP kinase phosphorylation. As predicted,
both activateand repress transcription, depending uponwe found that a transgene expressing a lin-31(VP16)
their association with corepressors (such as SMRT orchimeric activator caused a dominant Muv phenotype.
mSin3a) or coactivators (such as SRC-1, ACTR, andThis result suggests that the activation of LIN-31 target
CBP) (reviewed in Horwitz et al., 1996). The results ofgenes is sufficient to cause vulval precursor cells to
this work show how an activation/repression mecha-express vulval cell fates ectopically.
nism can beused ina developmental patterning context.Our work does not address the functional conse-
LIN-31 can both positively and negatively regulate vulvalquences of MAP kinase phosphorylation of LIN-1. lin-1
induction, and both functions are required for the properloss-of-function mutations do not obviously affect the
spatial specification of vulval cell fates. Vulval precursorspecification of vulval cell fates by P5.p, P6.p, and P7.p
cells are not fully activated if the positive function is(Beitel et al., 1995), unlike mutations in lin-31. Phosphor-
defective (resulting in a Vul phenotype), and they areylation of LIN-1 may thus inactivate its inhibitory func-
tion. Alternatively, LIN-1 phosphorylation may not be not fully inhibited if the negative function is defective
LIN-1 and LIN-31 Mediate MAP Kinase Signaling
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Experimental Procedures(resulting in a Muv phenotype). The ability of transcrip-
tion factors to both activate and repress gene expres-
General Methods and Strainssion may contribute to the precision and fidelity of gene Standard methods were used to handle C. elegans (variety Bristol,
transcription that characterizes many developmental strain N2) at 208C (Wood, 1988). Linkage group I (LG I): unc-
programs. 29(e1072). LG II: lin-31(n1053, ga37) (Miller et al., 1993). LG III: mpk-
1(ga117) (M. R. L. and S. K. K., unpublished data), dpy17(e164),
sDp3, LG V; him-5(e1490). Not yet assigned to a linkage group is
gaIs50(hs-lin-31; unc-29[1]). 18, 28, and 38 cell fates were assignedSignaling Specificity by the MAP Kinase Pathway
as described in Kornfeld (1997).
Our results also address the problem of signaling speci-
ficity, in which the activation of common upstream sig- Molecular Biology
naling components (such as Ras and MAP kinase) can Site-directed mutagenesis was performed using the Unique Site
Elimination procedure (Pharmacia) and verified by sequencing.elicit different responses in different cell types (Figure
7B). LIN-31 WH is most likely a tissue-specific effector
Germline Transformationof MAP kinase signaling. lin-31 mutations cause defects
Germline transformants were obtained by DNA microinjection (Melloin only one of the six processes in which mpk-1 signaling
et al., 1991). Concentrations of DNAs used: all lin-31-derived con-
is known to act, and the expression pattern of LIN-31 structs (100 mg/ml), unc-29(1) (F35D3, 100 mg/ml), rol-6 (pRF4, 80
WH indicates that LIN-31 can transduce the MAP kinase mg/ml). All results described in this work are based on the average
of at least three or more transmitting lines. Chromosomal integrationsignal only in the vulval precursor cells and possibly in
of the heat-shock lin-31 transgene was induced by g-irradiation. Forthe B cell progeny in the male tail. Furthermore, lin-31
heat-shock treatment, newly hatched worms (2±3 hr after hatching)is required to faithfully induce a vulval-specific response
were heat-shocked (338C, 30 min) and fixed for immunostaining 3±4
(increased LET-23 RTK expression), and lin-31 misex- hr later.
pression in a heterologous let-23 responsive cell (the
P12 posterior ectoblast) partially causes that cell to re- Generation of Antibodies and Immunofluorescence
Rabbit a-LIN-31 antibodies were generated (Josman Labs) usingspond like a vulval precursor cell by expressing a vulval
MBP-LIN-31 (Maltose-binding protein, NEB) as an immunogen, fol-specific marker. Significantly, we did not observe any
lowed by affinitypurification using a GST-LIN-31 column.Generationdramatic P12 lineage alterations in our lin-31 misexpres-
and purification of MBP-LIN-31 and GST-LIN-31 proteins were per-
sion experiments, indicating that lin-31 alone is not suffi- formed according to standard protocols (NEB, Pharmacia). Antibod-
cient to fully transform P12 into a vulval precursor cell. ies were used at dilutions of 1:200 for immunofluorescence and
One explanation is that other vulval-specific effectors 1:1000 for Western blotting. Both MH27 (used for staging) and
a-LET-23 antibodies were used at 1:1000 dilution. Generation ofbesides LIN-31 also mediate vulval signaling specificity.
a-LET-23 antibodies will be described elsewhere (A. Candia et al.,Expression of the full vulval fate by a heterologous cell
unpublished data). Worms were fixed according to Finney and Ruv-would thus require the simultaneous expression of all
kun (1990).
these multiple effectors.
In contrast to LIN-31 WH, LIN-1 Ets functions as a In Vitro Kinase Assays
Recombinant baculoviruses expressing GST-LIN-31 and FLAG-general effector of the mpk-1 signaling pathway, since
LIN-1 were produced and amplified in Sf9 cells using Baculogoldloss-of-function lin-1 mutations affect at least four of
(Pharmingen). Affinity purification was performed using glutathionethe six cell types that utilize Ras/MAP kinase signaling
beads (for GST-LIN-31) or a-FLAG beads (Kodak), according to
in C. elegans. One aspect of MAP kinase signalingspeci- standard protocols. All proteins were stored at 2808C. Kinase
ficity may thus involve the interaction between a general assays were performed using 0.1 mg of test protein, 1 unit activated
Ras/MAP kinase effector (LIN-1 Ets) and a tissue-spe- rat ERK2 (NEB), and 10 mCi 32P-ATP (for GST-LIN-31) or 0.5 mM
ATP (for FLAG-LIN-1) in kinase buffer. Reactions were incubated atcific effector (LIN-31WH, in the case of the vulval precur-
308C for 30 min. Phosphorylated complexes were resolved on 9%sor cells). The tissue-specific MAP kinase effectors may
SDS-PAGE gels, transferred to nitrocellulose filters, and analyzedregulate different sets of genes in different tissues. using phosphoimaging or Western blotting (a-LIN-31 or a-FLAG
MAP kinase phosphorylation of general factors are [Kodak]). All, or nearly all, of GST-LIN-31 and FLAG-LIN-1 are phos-
well known, but only recently have tissue-specific ef- phorylated under these conditions (Figures 2B and 3D).
fectors been found. In mammals, the bHLH transcription
Cell Culture and DNA Transfectionsfactor Microphthalmia and the PPARg nuclear receptor
Transfections into NIH 3T3 cells were performed in 60 mm dishesare tissue-specific effectors of MAP kinase signaling in
with 5 mg of total DNA using Superfect (Qiagen). Cells were har-
melanocyte and adipocyte differentiation, respectively vested 48 hr posttransfection for analysis on SDS-PAGE (12% for
(Hu et al., 1996; Hemesath et al., 1998). Like LIN-31, LIN-31 or LIN-31[PhD], and 9% for LIN-1). Vectors expressing
these tissue-specific effectors may interact with general H-Ras(V12) (pEF-Ras) and activated MEK1(DN3, S222D) were the
gifts of G. Crabtree (Stanford University) and M. Schwartz (Scrippseffectors (e.g., Elk-1) to initiate new programs of gene
Research Institute, La Jolla), respectively.expression. In Drosophila, the MAP kinase rolled may
directly regulate at least three transcription factors: Aop/
Binding Assays
Yan, PointedP2, and dJun. However, none of these tran- For coinfection experiments, Sf9 cells were coinfected with recom-
scription factors is tissue specific. Thus, the mechanism binant baculoviruses expressing FLAG-LIN-1 and either GST-LIN-
31 or GST-USP (gift from M. Arbeitman, Stanford University) at anof signaling specificity in Drosophila is currenly un-
M. O. I. of 3. Cells (5 3 106 cells in 1 ml) were lysed 48 hr postinfectionknown. Tissue-specific effectors of MAP kinase signal-
and recombinant proteins purified and analyzed on SDS-PAGE.ing may form an important class of proteins that confer
In vitro binding assays were performed using independently puri-
specificity onto generally used signaling pathways so fied GST-LIN-31 or FLAG-LIN-1. GST-LIN-31 (A, B, C) and GST-LIN-7
that diverse cellular outcomes can ultimately be gen- (gift of S. Kaech) were expressed and purified in Escherichia coli
under standard conditions (Pharmacia).erated.
Cell
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For further information regarding the Experimental Procedures, Leevers, S.J., and Marshall, C.J. (1992). Activation of extracellular
signal-regulated kinase, ERK2, by p21ras oncoprotein. EMBO J. 11,see our Website at http://cmgm.stanford.edu/zkimlab.
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